share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰製藥 | 4：持股變動聲明-董事 SACHS BRUCE I
美股sec公告 ·  05/04 04:28
牛牛AI助理已提取核心訊息
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on May 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Bruce I. Sachs to the issuer was not specified, and the table containing non-derivative securities information was left empty. Without these details, the impact of the transaction on Sachs' holdings and the overall market position of Vertex Pharmaceuticals remains unclear.
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on May 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Bruce I. Sachs to the issuer was not specified, and the table containing non-derivative securities information was left empty. Without these details, the impact of the transaction on Sachs' holdings and the overall market position of Vertex Pharmaceuticals remains unclear.
與Vertex Pharmicals Inc.（VRTX）有聯繫的布魯斯·薩克斯於2024年5月1日執行了一項交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。Bruce I. Sachs與發行人的關係沒有具體說明，包含非衍生證券信息的表格留空。如果沒有這些細節，該交易對薩克斯持股和Vertex Pharmicals整體市場地位的影響尚不清楚。
與Vertex Pharmicals Inc.（VRTX）有聯繫的布魯斯·薩克斯於2024年5月1日執行了一項交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。Bruce I. Sachs與發行人的關係沒有具體說明，包含非衍生證券信息的表格留空。如果沒有這些細節，該交易對薩克斯持股和Vertex Pharmicals整體市場地位的影響尚不清楚。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。